{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/DFTX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-10T06:02:16.520Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4533,"canonical_name":"Definium Therapeutics, Inc.","cik":"0001813814","uei":null,"lei":null,"duns":null,"ticker":"DFTX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":40},"count":40,"timeline":[{"ts":"2026-09-18","kind":"sec.insider.1629","reporter":"Krebs Andreas","title":null,"shares":1629,"price_per_share":35.52,"usd_value":57862,"security_title":"Common Shares","importance":15.05786208},{"ts":"2026-09-18","kind":"sec.insider.1086","reporter":"Vallone Carol A","title":null,"shares":1086,"price_per_share":35.52,"usd_value":38575,"security_title":"Common Shares","importance":15.03857472},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Definium Therapeutics, Inc. — 2026-06-26","url_slug":"/sec/cik-0001813814/4/0001193125-26-285562","accession_number":"0001193125-26-285562","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Definium Therapeutics, Inc. — 2026-06-26","url_slug":"/sec/cik-0001813814/4/0001193125-26-285564","accession_number":"0001193125-26-285564","importance":30},{"ts":"2026-06-25","kind":"sec.form144","reporter":"ROBERT B BARROW","title":"Officer, Director","shares":29208,"usd_value":1230533,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006487","importance":40.246106608},{"ts":"2026-06-25","kind":"sec.form144","reporter":"MARK SULLIVAN","title":"Officer","shares":13008,"usd_value":548027,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006493","importance":40.109605408},{"ts":"2026-06-25","kind":"sec.form144","reporter":"DANIEL ROLLINGS KARLIN","title":"Officer","shares":10035,"usd_value":422775,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006489","importance":40.08455491},{"ts":"2026-06-25","kind":"sec.form144","reporter":"BRANDI ROBERTS","title":"Officer","shares":3013,"usd_value":126938,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006491","importance":40.025387538},{"ts":"2026-06-25","kind":"sec.form144","reporter":"MATTHEW THOMAS WILEY","title":"Officer","shares":2867,"usd_value":120787,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006492","importance":40.024157342},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Barrow Robert","title":"Chief Executive Officer","shares":29208,"price_per_share":45.03,"usd_value":1315236,"security_title":"Common Shares","importance":36.31523624},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Sullivan Mark","title":"Chief Legal Officer","shares":13008,"price_per_share":45.03,"usd_value":585750,"security_title":"Common Shares","importance":35.58575024},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Karlin Daniel","title":"Chief Medical Officer","shares":10035,"price_per_share":45.03,"usd_value":451876,"security_title":"Common Shares","importance":35.45187605},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Roberts Brandi","title":"Chief Financial Officer","shares":3013,"price_per_share":45.03,"usd_value":135675,"security_title":"Common Shares","importance":35.13567539},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Wiley Matthew T.","title":"Chief Commercial Officer","shares":2867,"price_per_share":45.03,"usd_value":129101,"security_title":"Common Shares","importance":35.12910101},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Roberts Brandi — 2026-06-25","url_slug":"/sec/cik-0001516354/144/0001950047-26-006491","accession_number":"0001950047-26-006491","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Definium Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001813814/144/0001950047-26-006487","accession_number":"0001950047-26-006487","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Definium Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001813814/144/0001950047-26-006489","accession_number":"0001950047-26-006489","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"8-K","title":"8-K — Definium Therapeutics, Inc. — 2026-06-24","url_slug":"/sec/cik-0001813814/8-k/0001104659-26-077354","accession_number":"0001104659-26-077354","importance":35},{"ts":"2026-06-24","kind":"sec.filing","form_type":"424B5","title":"424B5 — Definium Therapeutics, Inc. — 2026-06-24","url_slug":"/sec/cik-0001813814/424b5/0001104659-26-077349","accession_number":"0001104659-26-077349","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Definium Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001813814/8-k/0001104659-26-076091","accession_number":"0001104659-26-076091","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Definium Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001813814/4/0001193125-26-276882","accession_number":"0001193125-26-276882","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Definium Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001813814/4/0001193125-26-276878","accession_number":"0001193125-26-276878","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"424B5","title":"424B5 — Definium Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001813814/424b5/0001104659-26-076393","accession_number":"0001104659-26-076393","importance":30},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Sullivan Mark","title":"Chief Legal Officer","shares":62500,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Roberts Brandi","title":"Chief Financial Officer","shares":62500,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Wiley Matthew T.","title":"Chief Commercial Officer","shares":62500,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Barrow Robert","title":"Chief Executive Officer","shares":375000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-22","kind":"sec.insider.a","reporter":"Karlin Daniel","title":"Chief Medical Officer","shares":100000,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-16","kind":"sec.filing","form_type":"S-8","title":"S-8 — Definium Therapeutics, Inc. — 2026-06-16","url_slug":"/sec/cik-0001813814/s-8/0001104659-26-074569","accession_number":"0001104659-26-074569","importance":30},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"GRYSKA DAVID W","title":null,"shares":4666,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Vallone Carol A","title":null,"shares":4666,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Krebs Andreas","title":null,"shares":4666,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Bruhn Suzanne Louise","title":null,"shares":4666,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"CRYSTAL ROGER","title":null,"shares":4666,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Adsett Roger","title":null,"shares":3555,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-05-19","kind":"sec.filing","form_type":"8-K","title":"8-K — Definium Therapeutics, Inc. — 2026-05-19","url_slug":"/sec/cik-0001813814/8-k/0001193125-26-229657","accession_number":"0001193125-26-229657","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Definium Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001813814/schedule-13g-a/0001172661-26-002054","accession_number":"0001172661-26-002054","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Definium Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001813814/8-k/0001193125-26-218251","accession_number":"0001193125-26-218251","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Definium Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001813814/def-14a/0001193125-26-182034","accession_number":"0001193125-26-182034","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Definium Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001813814/defa14a/0001193125-26-182066","accession_number":"0001193125-26-182066","importance":30}]}